Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

NUAK1

From Wikipedia, the free encyclopedia
(Redirected from ARK5)

NUAK1
Identifiers
AliasesNUAK1, ARK5, NUAK family kinase 1
External IDsOMIM: 608130; MGI: 1925226; HomoloGene: 8896; GeneCards: NUAK1; OMA:NUAK1 - orthologs
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
2.7.11.1
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_014840

NM_001004363

RefSeq (protein)

NP_055655
NP_055655.1

NP_001004363

Location (UCSC)Chr 12: 106.06 – 106.14 MbChr 10: 84.21 – 84.28 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

NUAK family SNF1-like kinase 1 also known as AMPK-related protein kinase 5 (ARK5) is an enzyme that in humans is encoded by the NUAK1 gene.[5][6][7]

Function

[edit]

Acts as a regulator of cellular senescence and cellular ploidy by mediating phosphorylation of 'Ser-464' of LATS1, thereby controlling its stability. Controls cell adhesion by regulating activity of the myosin protein phosphatase 1 (PP1) complex.[8]

Clinical significance

[edit]

ARK5 is important in tumor malignancy and invasiveness.[9]

Research findings

[edit]

ARK5 is often overexpressed in multiple myeloma cell lines.[10][11] ARK5 promotes tumor cell survival under regulation by Akt.[9]

ARK5 increases MT1-MMP production.[9] (MT1-MMP activates MMP-2 and MMP-9 which are involved in tumor metastasis.[9])

As a drug target

[edit]

ON123300 (a CDK4 inhibitor), also inhibits ARK5 and reduces proliferation of multiple myeloma and mantle cell lymphoma cell lines.[10]

Interactions

[edit]

NUAK1 has been shown to interact with USP9X[12] and Ubiquitin C.[12]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000074590 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000020032 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF, Esumi H (Dec 2002). "Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein" (PDF). J Biol Chem. 278 (1): 48–53. doi:10.1074/jbc.M206025200. PMID 12409306. S2CID 23605132.
  6. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Esumi H (Sep 2003). "ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation". Oncogene. 22 (40): 6177–82. doi:10.1038/sj.onc.1206899. PMID 13679856. S2CID 20975883.
  7. "Entrez Gene: NUAK1 NUAK family, SNF1-like kinase, 1".
  8. Protein Coding (2021-11-14). "NUAK1 Gene - NUAK Family Kinase 1". Gene Cards. Retrieved 2021-12-19.
  9. 1 2 3 4 Suzuki A, Lu J, Kusakai G, et al. (2004). "ARK5 is a tumor invasion-associated factor downstream of Akt signaling". Mol. Cell. Biol. 24 (8): 3526–35. doi:10.1128/MCB.24.8.3526-3535.2004. PMC 381626. PMID 15060171.
  10. 1 2 Multi-Target Drug Blocks Myeloma Proliferation. March 2016
  11. Deepak Perumal, et al. (2014). "Abstract 1324: Dual targeting of CDK4 and ARK5 using a novel kinase inhibitor ON123300 is effective in vitro and in vivo in Multiple Myeloma". Cancer Research. 74 (19_Supplement): 1324. doi:10.1158/1538-7445.AM2014-1324.
  12. 1 2 Al-Hakim AK, Zagorska Anna, Chapman Louise, Deak Maria, Peggie Mark, Alessi Dario R (Apr 2008). "Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains" (PDF). Biochem. J. 411 (2). England: 249–60. doi:10.1042/BJ20080067. PMID 18254724. S2CID 13038944.

Further reading

[edit]